Safety study of HW252001 in healthy adults
Part of Lungs & breathing clinical trials.
This study tests a new investigational drug, HW252001, in healthy volunteers to see how safe it is and how the body handles it. If you qualify, you would help researchers find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old
- You must be in good general health with no major medical conditions
- Your body mass index (BMI) must be between 19 and 26
- No history of cancer except for certain cured or early-stage types
- No heavy smoking (more than 5 cigarettes a day) or heavy drinking recently
- No blood donation of 400 mL or more in the past 8 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
This study tests a new inhaled powder (RC010) to see if it is safe and how the body processes it. It is for healthy adults who do not smoke and have no major health problems.
This study is testing a new investigational drug called HW241045 in healthy volunteers. The main goal is to check how the drug is processed by the body and whether it is safe, which helps find the right dose for future studies.
This trial tests a new drug called HW243040 in healthy adults to see how safe it is. It helps researchers understand how the drug works in the body before testing it in patients with a condition.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This trial tests a new medication (called BW-20805-2-1001) in healthy volunteers to see if it is safe and how the body handles it. It may help in developing future treatments for certain diseases, though it's not yet known if it will benefit you directly.
Hear when a new IPF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.